# Comparison Between Rebamipide 2% Versus Autologous Serum

> **NCT03608761** · PHASE4 · COMPLETED · sponsor: **Hospital Nacional Profesor Alejandro Posadas** · enrollment: 21 (actual)

## Conditions studied

- Dry Eye Syndromes
- Sjögren Syndrome

## Interventions

- **DRUG:** Rebamipide
- **BIOLOGICAL:** autologous serum
- **OTHER:** autologous serum and rebamipide 2%

## Key facts

- **NCT ID:** NCT03608761
- **Lead sponsor:** Hospital Nacional Profesor Alejandro Posadas
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-06
- **Primary completion:** 2017-10-09
- **Final completion:** 2018-07-09
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2018-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03608761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03608761, "Comparison Between Rebamipide 2% Versus Autologous Serum". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03608761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*